Valley Wealth Managers’s KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) KBIO Stock Holding History

Valley Wealth Managers’s Portfolio KBIO Stock Details KBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-1,983	Closed	-$8K	–	104
2015 Q2	$8K	Hold	1,983	–	–	﹤0.01%	99
2015 Q1	$8K	Hold	1,983	–	–	﹤0.01%	101
2014 Q4	$27K	Hold	1,983	–	–	﹤0.01%	104
2014 Q3	$25K	Hold	1,983	–	–	﹤0.01%	102
2014 Q2	$36K	Buy	+1,983	New	+$33.9K	0.01%	106

Other funds holding KBIO

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

ARTA

A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

OWIM

Old West Investment Management Los Angeles, California $923M AUM 112.31% 1-Year Est. Return

Valley Wealth Managers's KBIO Position: Q3 2015 in Review

Valley Wealth Managers sold out of KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) (KBIO) in Q3 2015, closing a stake of 1,983 shares — an estimated $8K sold.

Valley Wealth Managers first reported a position in KBIO in Q2 2014 and held it in 5 quarters. The position peaked at $36K in Q2 2014. 14 funds tracked by Wall St. Rank hold KBIO as of Q3 2015.

Valley Wealth Managers reported no remaining KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position as of Q3 2015 after selling out during the quarter.
Valley Wealth Managers sold 1,983 KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) shares in Q3 2015, an estimated $8K.
Valley Wealth Managers first reported a position in KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) in Q2 2014 and held it in 5 quarters.
Valley Wealth Managers's KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position peaked at $36K in Q2 2014.
14 funds tracked by Wall St. Rank held KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) as of Q3 2015.

Based on Valley Wealth Managers's 13F filing for Q3 2015, filed 30 Oct 2015.